Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

113
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
113
Drug Therapy01:28

Drug Therapy

96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
96
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

141
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
141
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

267
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
267
Panic Disorder01:27

Panic Disorder

173
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
173

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pragmatic Algorithm for Selecting Psychopharmacology Treatment for Secondary Insomnia.

Journal of clinical psychopharmacology·2026
Same authorSame journal

Psychopharmacology Treatment of Schizoaffective Disorder.

Psychiatry and clinical psychopharmacology·2026
Same author

A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings.

Journal of clinical psychopharmacology·2025
Same author

Use of Wearable Sleep Data in the Treatment of Post-traumatic Stress Disorder: Insights From Subject Matter Experts.

Military medicine·2025
Same author

Ten Years of Bipolar Telehealth: Program Evaluation of a Team-Based Telemental Health Clinic.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2024
Same author

Charles Bonnet Syndrome Associated With Recurrent Hypertensive Crisis.

Journal of psychiatric practice·2022

Related Experiment Video

Updated: Sep 9, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

515

Posttraumatic Stress Disorder Psychopharmacology Algorithm Update-2024-2025.

Laura A Bajor1,2,3, Charmi Balsara4, David N Osser5,3

  • 1Mental Health & Behavioral Sciences Service, James A. Haley Veterans' Hospital, Tampa, United States.

Psychiatry and Clinical Psychopharmacology
|August 29, 2025
PubMed
Summary

Prazosin is the primary treatment for Posttraumatic Stress Disorder (PTSD) sleep issues. For persistent daytime symptoms, selective serotonin reuptake inhibitors (SSRIs) or other options may be considered, with emerging treatments still under evaluation.

More Related Videos

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.1K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.2K

Related Experiment Videos

Last Updated: Sep 9, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

515
Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.1K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.2K

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Clinical Psychiatry

Background:

  • The Psychopharmacology Algorithm Project at the Harvard South Shore Program last updated its Posttraumatic Stress Disorder (PTSD) algorithm in 2022.
  • New evidence has emerged, reinforcing existing treatment recommendations for PTSD.

Purpose of the Study:

  • To provide an updated, evidence-informed approach to the pharmacological management of Posttraumatic Stress Disorder (PTSD).
  • To integrate the latest research findings into clinical practice guidelines for PTSD treatment.

Main Methods:

  • Review and synthesis of recent clinical evidence and research findings related to PTSD pharmacotherapy.
  • Evaluation of established and emerging treatment options based on efficacy and supporting data.

Main Results:

  • Prazosin is confirmed as the first-line treatment for PTSD-related sleep disturbances (nightmares, disturbed awakenings).
  • Selective serotonin reuptake inhibitors (SSRIs) are recommended for residual daytime symptoms post-insomnia treatment, potentially augmented by antipsychotics.
  • Second-line SSRIs or SNRIs may be considered if initial treatments are unsatisfactory, though they do not target hyperarousal.
  • Emerging treatments (TMS, DCS, stellate ganglion block, pimavanserin) are noted but not yet integrated into the core algorithm due to insufficient evidence.

Conclusions:

  • The updated algorithm prioritizes prazosin for sleep impairment and SSRIs for daytime symptoms in PTSD management.
  • Clinicians are guided by the latest evidence for effective pharmacological treatment of PTSD.
  • Further research is needed to establish the role of emerging therapies in the core PTSD treatment algorithm.